Buy Lsd Liquid Online https://psychedelicmins.com
This article is more than 1 month old
Australian decision to allow psychedelic drug prescriptions criticised by mental health experts says Buy Lsd Liquid Online
Buy-Ayahuasca-Tea-Online
This article is more than 1 month old/lsd liquid gel tabs for sale online
Neuropsychologists and psychiatrists argue the evidence for broad-scale implementation of psychedelic drug use is insufficient Buy Lsd Liquid Online
- Get our morning and afternoon news emails, free app or daily news podcast
Melissa Davey Medical editor
@MelissaLDaveyWed 5 Jul 2023 16.00 BST
The decision by Australia’s drug regulator to allow authorised psychiatrists to prescribe psychedelic drugs is “questionable, if not concerning”, and likely driven by the influence of lobby groups instead of health experts, mental health researchers say. Buy Lsd Liquid Online
As of 1 July, authorised psychiatrists have been able to prescribe medicines containing psilocybin for treatment-resistant depression, and MDMA for post-traumatic stress disorder. The decision by the Therapeutic Goods Administration followed public consultation, a report from an expert panel and advice received from a medicine advisory committee. Buy Lsd Liquid Online
But in a commentary published in the latest edition of the Australian New Zealand Journal of Psychiatry, neuropsychologists and neuroscientists have questioned why the TGA did not consult with researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder. The authors of the piece have the only registered active research trial in psilocybin-assisted psychotherapy for major depressive disorder in Australia.
Hurricane Hilary downgraded amid warnings of‘catastrophic’ floodin
“It seems the TGA has yielded to pressure from the public and lobby groups to increase access to these experimental treatments, outside of clinical trials,” said writers, led by Prof Susan Rossell, a cognitive neuropsychologist at Swinburne’s Centre for Mental Health. Buy Lsd Liquid Online
“Despite what the TGA published in its announcement, sufficient levels of evidence have not yet been generated for broad-scale implementation to be justified. Initial results have been promising by most standards, yet many questions remain.” Buy Lsd Liquid Online
Rossell and her colleagues wrote that it is still unclear what kind of care needs to be delivered alongside the psychedelic dosing to ensure ongoing benefit; what the long-term safety profile of the drugs are, especially in terms of psychological recovery and relapse; and how to differentiate those patients who may benefit from those for whom it could be detrimental. Buy Lsd Liquid Online
“Until these questions have been addressed in empirical research, the decision to increase public access outside of clinical trials is questionable, if not concerning,” the piece concluded.Buy Lsd Liquid Online
A TGA spokesperson said: “The process for changes to MDMA and psilocybin access through scheduling in the Poisons Standard was not influenced by lobby groups and media stories.Buy Lsd Liquid Online
“The decision to change access to MDMA and psilocybin acknowledged that evidence for the use of these substances in treating mental illnesses is not yet well established, echoing some public consultation submissions,” he said. Buy Lsd Liquid Online
“However, the benefits for some patients from treatment with psilocybin or MDMA under the supervision of an authorised psychiatrist will outweigh the risks, and there is currently a lack of options for patients with specific treatment-resistant mental illnesses.” Buy Lsd Liquid Online
The spokesman said while the TGA recognised there was potential vulnerability of patients undergoing psychedelic-assisted psychotherapy, it was satisfied there were appropriate safeguards. Buy Lsd Liquid Online
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has released the first of a series of guidance documents for psychiatrists using psychedelic-assisted therapy. The document emphasises the importance of a “safety first” approach to protect the most vulnerable.
Prof Colleen Loo, a clinical psychiatrist who has long been researching the role of ketamine in treatment-resistant depression, agreed with the authors of the Australian New Zealand Journal of Psychiatry paper that any evidence supporting ketamine use was in its early stages.skip past newsletter promotion Buy Lsd Liquid Online
Sign up to Afternoon Update
Free daily newsletter
Finish your day with Antoun Issa’s three-minute snapshot of Australia’s main news
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LdzlmsdAAAAALFH63cBVagSFPuuHXQ9OfpIDdMc&co=aHR0cHM6Ly93d3cudGhlZ3VhcmRpYW4uY29tOjQ0Mw..&hl=en&type=image&v=x19joXI_IeQnFJ7YnfDapSZq&theme=light&size=invisible&badge=bottomright&cb=eixsuzxrukuzPrivacy Notice: Newsletters may contain info about charities, online ads, and content funded by outside parties. For more information see our Privacy Policy. We use Google reCaptcha to protect our website and the Google Privacy Policy and Terms of Service apply.
after newsletter promotion
“I am not privy to the reasons why the TGA made its decision, though it is clear from media discussion of psychedelics preceding their decision that there was immense pressure from lobby groups to downschedule the drugs,” Loo said.
“It is clear from the published literature that the door has been opened to clinical use much earlier in the development pathway than usual. Usually, a series of research studies are done, and approval for clinical use only occurs after there is substantive data on efficacy and safety.
“Nevertheless the decision has been made and the door opened.
“In my experience as a clinical psychiatrist and researcher, in many cases where people tell me nothing has worked for them, there are useful proven treatments which have not been tried,” she said.
“I think taking this first step – seeing an independent psychiatrist – makes sense both clinically to get the best care and before one commits to a treatment with less evidence base than other treatments, but costing $10[k] to $30k.”
Rossell said she felt compelled to write to the journal because she was concerned that pro-psychedelic lobby groups “will move forward to such an extent with these interventions that we are going to see some significant adverse events”.
“This will obviously be terrible for the patients but also a burden for researchers and clinicians who are trying to do the right thing in this space.”
… there is a good reason why not to support the Guardian.
Not everyone can afford to pay for news right now. That is why we keep our journalism open for everyone to read, including in Colombia. If this is you, please continue to read for free.
But if you are able to, then there are three good reasons to support us today.
1. Our quality, investigative journalism is a scrutinising force at a time when the rich and powerful are getting away with more and more
2. We are independent and have no billionaire owner pulling the strings, so your money directly powers our reporting
3. It doesn’t cost much, and takes less time than it took to read this message
Help power the Guardian’s journalism for the years to come, whether with a small sum or a larger one. If you can, please support us on a monthly basis from just $2. It takes less than a minute to set up, and you can rest assured that you’re making a big impact every single month in support of open, independent journalism. Thank you.
